01 January 2001
Statin-stimulated nitric oxide release from endothelium.
Lawrence W Dobrucki, Leszek Kalinowski, Iwona T Dobrucki, Tadeusz MalinskiMed Sci Monit 2001; 7(4): BR622-627 :: ID: 421094
Abstract
BACKGROUND: There is increasing evidence that loss of endothelium-derivedNO is a major factor in cardiovascular complication events, and that NO might exert antiatheroscleroticactions. The beneficial effects of HMG CoA reductase inhibitors (statins) therapy in atherosclerosisoutweigh those expected from simply lowering low-density lipoprotein (LDL) cholesterol, and may be relatedto the direct action in the endothelium. Based on these concepts, in the studies described here, theeffect of new statin derivatives on nitric oxide (NO) and superoxide (O2-) release in bovine endothelialcells was tested.MATERIAL AND METHODS: Highly sensitive electrochemical NO and O2--microsensors wereplaced near the surface of endothelial cells, and the concurrent kinetics of NO and O2-- release weremeasured in situ.RESULTS: All tested statins stimulated NO release. The peak concentration of NO afterstimulation with 1 Kmol/l Lovastatin, 1 Kmol/l Atorvastatin, 1 Kmol/l Pravastatin, or 1 Kmol/l Simvastatinwas about 77%, 73%, 72%, and 44% lower, respectively, as compared with the NO peak concentration afterstimulation with 1 Kmol/l calcium ionophore A23187 (receptor-independent agonist). The tested statinsstimulated NO release in a modest way, which resulted in diminishing O2- generation during activationof nitric oxide synthase. Moreover, the kinetics of O2- release after administration of the statins suggestedthat these compounds may also scavenge O2-. The NO/O2- peak concentration ratio after the NOS agonistsadministration was as follows: 7.51 for CaI, 6.56 for Lovastatin, 6.00 for Atorvastatin, 4.17 for Pravastatinand 6.25 for Simvastatin.CONCLUSIONS: The tested statins, i.e. Lovastatin, Atorvastatin, Pravastatinand Simvastatin demonstrate variable potency to enhance the NO/O2- concentration ratio after stimulationof NOS, resulting in an increase of NO bioavailability in endothelial cells.
Keywords: statins, Endothelium, Nitric Oxide, superoxide
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Clinical Research
Risk Factors for Bone Cement Displacement After Percutaneous Kyphoplasty in Osteoporotic Vertebral Fracture...Med Sci Monit In Press; DOI: 10.12659/MSM.945884
Clinical Research
Adipose-Derived Mesenchymal Stem Cells from Arthritis Patients: Differential Modulation of CD4⁺ T Cell Acti...Med Sci Monit In Press; DOI: 10.12659/MSM.945273
Review article
Surgical Advances in the Treatment of Acromioclavicular Joint Injury: A Comprehensive ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.942969
Clinical Research
Analysis of Mortality Causes and Locations in Veterans with ALS: A Decade ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.945816
Most Viewed Current Articles
17 Jan 2024 : Review article 6,477,415
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,909,282
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,637
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 261,758
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074